United Laboratories Intl Overview

  • Status
  • Public

  • Employees
  • 15,000

Employees

  • Stock Symbol
  • 03933

Stock Symbol

  • Share Price
  • $1.04
  • (As of Friday Closing)

United Laboratories Intl General Information

Description

United Laboratories International Holdings Ltd is a drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Majority of the company's sales are generated in China, followed by Europe, India and other countries.

Contact Information

Website
www.tul.com.cn
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
HKG
Corporate Office
  • Hong Kong
  • Hong Kong

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

United Laboratories Intl Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.04 $1.08 $0.75 - $1.38 $1.88B 1.82B 4.15M $0.21

United Laboratories Intl Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 1,184,300 1,184,300 859,893 810,144
Revenue 1,942,065 1,942,065 1,683,005 1,502,759
EBITDA 547,186 547,186 381,623 278,912
Net Income 381,823 381,823 234,774 153,026
Total Assets 2,964,927 2,964,927 2,750,949 2,562,106
Total Debt 212,127 212,127 356,962 289,000
Public Fundamental Data provided by Morningstar, Inc. disclaimer

United Laboratories Intl Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

United Laboratories Intl ESG

Risk Overview

Risk Rating

Updated March, 23, 2024

26.1 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 16,216

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 921

Rank

00.00

Percentile

Pharmaceuticals

Subindustry

00 of 452

Rank

00.00

Percentile

To view United Laboratories Intl’s complete esg history, request access »

United Laboratories Intl FAQs

  • Where is United Laboratories Intl headquartered?

    United Laboratories Intl is headquartered in Hong Kong, Hong Kong.

  • What is the size of United Laboratories Intl?

    United Laboratories Intl has 15,000 total employees.

  • What industry is United Laboratories Intl in?

    United Laboratories Intl’s primary industry is Pharmaceuticals.

  • Is United Laboratories Intl a private or public company?

    United Laboratories Intl is a Public company.

  • What is United Laboratories Intl’s stock symbol?

    The ticker symbol for United Laboratories Intl is 03933.

  • What is the current stock price of United Laboratories Intl?

    As of 19-Jul-2024 the stock price of United Laboratories Intl is $1.04.

  • What is the current market cap of United Laboratories Intl?

    The current market capitalization of United Laboratories Intl is $1.88B.

  • What is United Laboratories Intl’s current revenue?

    The trailing twelve month revenue for United Laboratories Intl is $1.94B.

  • What is United Laboratories Intl’s annual earnings per share (EPS)?

    United Laboratories Intl’s EPS for 12 months was $0.21.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »